Japanese Pharmaceutical Company Aims to Develop Lower-Dose Actos into Alzheimer’s Treatment Takeda Pharmaceuticals and its partner, Zinfandel Pharma, have started a Phase III trial of
Many veterans and their families who lived at Camp Lejeune between 1953 and 1987 have died or developed serious health complications from consuming contaminated water
Judge Will Not Overturn Actos Verdict, Takeda Still Owes $9 Billion Takeda Pharmaceuticals and Eli Lilly still owe plaintiffs in the first Actos verdict $9 billion
Nevada Actos Product Liability Lawsuit Moves Forward In 2013, two Nevada residents filed product liability lawsuits against Takeda Pharmaceuticals because they took Actos to treat
After Initial Loss, DePuy Faces Second Personal Injury Lawsuit, Admits Recall for Defects On March 8th, a Los Angeles jury awarded Loren Kransky $8.3 million
Two New Plaintiffs Assert Actos Bladder Cancer Claims Two lawsuits in state court claim that Actos led to the development of bladder cancer, and in one
Actos Bladder Cancer Lawsuit Actos is a recent drug in the thiazolidinedione class. It is used by itself or in combination with other drugs (including insulin)
Watson Pharmaceuticals has filed a lawsuit against the FDA for denying shared exclusivity despite the drug company following all the FDA’s requirements. Watson planned to release
The families of two men who died of bladder cancer have filed lawsuits against Takeda Pharmaceuticals, manufacturers of Actos, a Type 2 diabetes medication. The
Reports of Heart Failure Lead to FDA Probe into AstraZeneca Diabetes Drugs On Tuesday, February 11th, the Food and Drug Administration (FDA) announced that it